Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
AstraZeneca
Cipla
Moodys
Cerilliant
Fuji
Julphar
Citi

Generated: January 22, 2019

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and twenty-three approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 040321-001 Feb 5, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth PEMOLINE pemoline TABLET;ORAL 075595-002 Feb 28, 2000 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 091422-001 Feb 22, 2013 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth ALPRAZOLAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 078561-004 Mar 16, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Elizabeth BETHANECHOL CHLORIDE bethanechol chloride TABLET;ORAL 040551-001 Oct 28, 2004 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Baxter
Healthtrust
Covington
Farmers Insurance
Mallinckrodt
Dow
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.